D-0249-2022 Class I Terminated
FDA drug recall D-0249-2022 was initiated by Bayer Healthcare Pharmaceuticals Inc. on October 1, 2021 and is designated Class I. Reason for recall: Chemical Contamination: presence of benzene The recall status is terminated (terminated June 26, 2023). Affected quantity: 579,456 cans.
Recall Details
- Product Type
- Drugs
- Report Date
- November 24, 2021
- Initiation Date
- October 1, 2021
- Termination Date
- June 26, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 579,456 cans
Product Description
Lotrimin AF (Tolnaftate 1%) Daily Prevention deodorant powder spray, NET WT 160g (5.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, UPC 0 41100 58720 6, NDC 11523-0010-2.
Reason for Recall
Chemical Contamination: presence of benzene
Distribution Pattern
Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.
Code Information
Lot # TN0023D, EXP 2/28/2022; TN004BX, EXP 6/30/2022;